Renascience Statistics
Total Valuation
Renascience has a market cap or net worth of JPY 10.83 billion. The enterprise value is 7.64 billion.
Important Dates
The last earnings date was Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Renascience has 13.78 million shares outstanding. The number of shares has increased by 5.50% in one year.
| Current Share Class | 13.78M |
| Shares Outstanding | 13.78M |
| Shares Change (YoY) | +5.50% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 21.08% |
| Owned by Institutions (%) | 0.56% |
| Float | 10.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 159.24 |
| PB Ratio | 3.42 |
| P/TBV Ratio | 3.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 112.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 35.05, with zero debt.
| Current Ratio | 35.05 |
| Quick Ratio | 34.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.84% and return on invested capital (ROIC) is -8.71%.
| Return on Equity (ROE) | -12.84% |
| Return on Assets (ROA) | -8.34% |
| Return on Invested Capital (ROIC) | -8.71% |
| Return on Capital Employed (ROCE) | -10.42% |
| Weighted Average Cost of Capital (WACC) | 14.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Renascience has paid 1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.51% in the last 52 weeks. The beta is 1.84, so Renascience's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -57.51% |
| 50-Day Moving Average | 1,027.06 |
| 200-Day Moving Average | 1,417.95 |
| Relative Strength Index (RSI) | 29.27 |
| Average Volume (20 Days) | 198,305 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Renascience had revenue of JPY 68.00 million and -304.00 million in losses. Loss per share was -22.67.
| Revenue | 68.00M |
| Gross Profit | 64.00M |
| Operating Income | -330.00M |
| Pretax Income | -303.00M |
| Net Income | -304.00M |
| EBITDA | n/a |
| EBIT | -330.00M |
| Loss Per Share | -22.67 |
Full Income Statement Balance Sheet
The company has 3.19 billion in cash and no debt, with a net cash position of 3.19 billion or 231.76 per share.
| Cash & Cash Equivalents | 3.19B |
| Total Debt | n/a |
| Net Cash | 3.19B |
| Net Cash Per Share | 231.76 |
| Equity (Book Value) | 3.17B |
| Book Value Per Share | 229.88 |
| Working Capital | 3.17B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -266.00M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -266.00M |
| FCF Per Share | -19.31 |
Full Cash Flow Statement Margins
| Gross Margin | 94.12% |
| Operating Margin | -485.29% |
| Pretax Margin | -445.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Renascience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.50% |
| Shareholder Yield | -5.50% |
| Earnings Yield | -2.88% |
| FCF Yield | -2.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Renascience has an Altman Z-Score of 136.94 and a Piotroski F-Score of 2.
| Altman Z-Score | 136.94 |
| Piotroski F-Score | 2 |